Investor Relations
Bursa Announcements
Stock Name / Code :
PHARMA ( 7081 )
Year :
2024
2023
2022
2021
2020
Archives
Select date range :
News Type :
Category
Additional Listing Announcement
Annual Audited Accounts
Annual Reports
Change of Corporate Information
Changes in Shareholdings
Circulars/Notice to Shareholders
Dealings in Listed Securities (Chapter 14 of Listing Requirements)
Delisting of Securities
Disclosure On Quarterly Production
Entitlements
Expiry / Maturity / Termination of Securities
Financial Results
General Announcement
General Meetings
Important Relevant Dates for Renounceable Rights
Investor Alert
IPO Announcement/LEAP Market Announcement
Listing Circulars
Listing Information and Profile
Prospectus
Reply to Query
Shares Buy Back
Special Announcements
Take-over Offer
Transfer of Listing
Unusual Market Activity
Friday - 28 Apr 2023
CIRCULAR TO SHAREHOLDERS IN RELATION TO THE PROPOSED RENEWAL OF SHAREHOLDERS' MANDATE FOR RECURRENT RELATED PARTY TRANSACTIONS OF A REVENUE OR TRADING NATURE
Tuesday - 18 Apr 2023
TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : RECURRENT RELATED PARTY TRANSACTIONS PHARMANIAGA BERHAD ("PB" OR "THE COMPANY") CIRCULAR TO SHAREHOLDERS IN RELATION TO THE PROPOSED RENEWAL OF SHAREHOLDERS' MANDATE FOR RECURRENT RELATED PARTY TRANSACTIONS OF A REVENUE OR TRADING NATURE
Monday - 3 Apr 2023
PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT
Tuesday - 28 Mar 2023
OTHERS
APPOINTMENT OF PRINCIPAL ADVISER FOR THE REGULARISATION PLAN PURSUANT TO PRACTICE NOTE 17 OF THE MAIN MARKET LISTING REQUIREMENTS OF BURSA MALAYSIA SECURITIES BERHAD
Tuesday - 14 Mar 2023
Change in Principal Officer - DATUK ZULKARNAIN MD EUSOPE
OTHERS
ESTABLISHMENT OF AN EXECUTIVE COMMITTEE AND PN17 BOARD COMMITTEE TASKFORCE FOLLOWING THE RESIGNATION OF THE CHIEF EXECUTIVE COMMITTEE
Tuesday - 28 Feb 2023
PRACTICE NOTE 17 / GUIDANCE NOTE 3 : FIRST ANNOUNCEMENT
FINANCIAL CONDITION
PHARMA - New admission into PN17
Monday - 27 Feb 2023
Quarterly rpt on consolidated results for the financial period ended 31 Dec 2022
PRACTICE NOTE 17 / GUIDANCE NOTE 3 : FIRST ANNOUNCEMENT
Thursday - 23 Feb 2023
Change in Nomination and Remuneration Committee - ENCIK AHMAD SHAHREDZUAN BIN MOHD SHARIFF (Amended Announcement)
Wednesday - 22 Feb 2023
Change in Audit Committee - ENCIK IZADDEEN BIN DAUD
Change in Audit Committee - ENCIK AHMAD SHAHREDZUAN BIN MOHD SHARIFF
Change in Boardroom - DATUK ZULKARNAIN MD EUSOPE
«
1
2
3
4
5
6
7
8
9
10
»